Malathi Anantha

1.2k total citations
37 papers, 1.0k citations indexed

About

Malathi Anantha is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Malathi Anantha has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Oncology and 17 papers in Biomaterials. Recurrent topics in Malathi Anantha's work include Nanoparticle-Based Drug Delivery (17 papers), RNA Interference and Gene Delivery (8 papers) and Cancer therapeutics and mechanisms (8 papers). Malathi Anantha is often cited by papers focused on Nanoparticle-Based Drug Delivery (17 papers), RNA Interference and Gene Delivery (8 papers) and Cancer therapeutics and mechanisms (8 papers). Malathi Anantha collaborates with scholars based in Canada, Sweden and Netherlands. Malathi Anantha's co-authors include Marcel B. Bally, Murray S. Webb, Mohamed Wehbe, Katarina Edwards, Nancy Dos Santos, Ada W.Y. Leung, Göran Karlsson, Christine Allen, Ryan Gallagher and Lacey Samuels and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Malathi Anantha

36 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malathi Anantha Canada 19 550 518 292 194 86 37 1.0k
Niravkumar R. Patel United States 15 540 1.0× 606 1.2× 393 1.3× 228 1.2× 80 0.9× 16 1.1k
Mark Hayes United States 14 558 1.0× 503 1.0× 241 0.8× 167 0.9× 57 0.7× 21 983
Yogita P. Patil India 10 485 0.9× 461 0.9× 301 1.0× 112 0.6× 62 0.7× 14 1.0k
Arthur Rekechenetskiy United States 7 335 0.6× 444 0.9× 342 1.2× 158 0.8× 112 1.3× 7 842
Natashia Harasym Canada 10 564 1.0× 610 1.2× 329 1.1× 213 1.1× 49 0.6× 14 1.1k
Gregory J.R. Charrois Canada 11 473 0.9× 678 1.3× 443 1.5× 150 0.8× 89 1.0× 12 1.1k
Michael Teifel Germany 15 602 1.1× 483 0.9× 300 1.0× 222 1.1× 39 0.5× 34 1.1k
Sara Zalba Spain 17 604 1.1× 520 1.0× 370 1.3× 204 1.1× 83 1.0× 29 1.2k
Dawn Waterhouse Canada 20 704 1.3× 568 1.1× 360 1.2× 308 1.6× 75 0.9× 36 1.4k
Daniela Fraier United Kingdom 14 496 0.9× 565 1.1× 319 1.1× 220 1.1× 62 0.7× 27 1.2k

Countries citing papers authored by Malathi Anantha

Since Specialization
Citations

This map shows the geographic impact of Malathi Anantha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malathi Anantha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malathi Anantha more than expected).

Fields of papers citing papers by Malathi Anantha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malathi Anantha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malathi Anantha. The network helps show where Malathi Anantha may publish in the future.

Co-authorship network of co-authors of Malathi Anantha

This figure shows the co-authorship network connecting the top 25 collaborators of Malathi Anantha. A scholar is included among the top collaborators of Malathi Anantha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malathi Anantha. Malathi Anantha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leung, Ada W.Y., Roger Gilabert‐Oriol, Jayesh A. Kulkarni, et al.. (2025). Liposomal delivery of a disulfiram metabolite drives copper-mediated tumor immunity. International Journal of Pharmaceutics. 683. 126010–126010.
2.
Dragowska, Wieslawa H., Jagbir Singh, Mohamed Wehbe, et al.. (2024). Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo. Pharmaceutics. 17(1). 42–42. 2 indexed citations
3.
Leung, Ada W.Y., Gemma M. Ryan, Malathi Anantha, et al.. (2022). DMPC/Chol liposomal copper CX5461 is therapeutically superior to a DSPC/Chol formulation. Journal of Controlled Release. 345. 75–90. 11 indexed citations
4.
Anantha, Malathi, et al.. (2021). Development and characterization of a novel flavopiridol formulation for treatment of acute myeloid leukemia. Journal of Controlled Release. 333. 246–257. 21 indexed citations
5.
Charest, Gabriel, Minghan Shi, Mohamed Wehbe, et al.. (2020). Concomitant Chemoradiation Therapy with Gold Nanoparticles and Platinum Drugs Co-Encapsulated in Liposomes. International Journal of Molecular Sciences. 21(14). 4848–4848. 26 indexed citations
6.
Anantha, Malathi, Ada W.Y. Leung, Jayesh A. Kulkarni, et al.. (2019). Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use. Drug Delivery and Translational Research. 10(1). 202–215. 29 indexed citations
7.
Leung, Ada W.Y., Malathi Anantha, Wieslawa H. Dragowska, Mohamed Wehbe, & Marcel B. Bally. (2018). Copper-CX-5461: A novel liposomal formulation for a small molecule rRNA synthesis inhibitor. Journal of Controlled Release. 286. 1–9. 19 indexed citations
8.
Shi, Minghan, Malathi Anantha, Mohamed Wehbe, et al.. (2018). Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats. Journal of Nanobiotechnology. 16(1). 77–77. 43 indexed citations
9.
Wehbe, Mohamed, Malathi Anantha, Minghan Shi, et al.. (2017). Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent. International Journal of Nanomedicine. Volume 12. 4129–4146. 58 indexed citations
10.
Gilabert‐Oriol, Roger, et al.. (2017). In vitro assay for measuring real time topotecan release from liposomes: release kinetics and cellular internalization. Drug Delivery and Translational Research. 7(4). 544–557. 7 indexed citations
11.
Wehbe, Mohamed, Malathi Anantha, Cody Lo, et al.. (2017). Development of a copper-clioquinol formulation suitable for intravenous use. Drug Delivery and Translational Research. 8(1). 239–251. 32 indexed citations
12.
Wehbe, Mohamed, Malathi Anantha, Ada W.Y. Leung, et al.. (2017). A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer. Journal of Controlled Release. 252. 50–61. 38 indexed citations
13.
Waterhouse, Dawn, Brent W. Sutherland, Nancy Dos Santos, et al.. (2014). Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities. Investigational New Drugs. 32(6). 1071–1082. 12 indexed citations
14.
Waterhouse, Dawn, et al.. (2012). Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancer. Investigational New Drugs. 31(1). 46–58. 24 indexed citations
15.
16.
17.
Anantha, Malathi, et al.. (2010). The Role of the Transition Metal Copper and the Ionophore A23187 in the Development of Irinophore C™. Pharmaceutical Research. 28(4). 848–857. 8 indexed citations
18.
Santos, Nancy Dos, Christine Allen, Malathi Anantha, et al.. (2007). Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: Relating plasma circulation lifetimes to protein binding. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1768(6). 1367–1377. 292 indexed citations
19.
Ramsay, Euan, et al.. (2005). Enhanced liposomal retention of irinotecan is correlated to increases in plasma irinotecan AUC and improved efficacy against a model of colorectal cancer. Cancer Research. 65. 325–326. 1 indexed citations
20.
Ramsay, Euan, Malathi Anantha, Awa Dicko, et al.. (2004). A novel approach to prepare a liposomal irinotecan formulations that exhibit significant therapeutic activity in vivo. Cancer Research. 64. 148–148. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niravkumar R. Patel Breakdown of academic impact, for papers by Mark Hayes Breakdown of academic impact, for papers by Yogita P. Patil Breakdown of academic impact, for papers by Arthur Rekechenetskiy Breakdown of academic impact, for papers by Natashia Harasym Breakdown of academic impact, for papers by Gregory J.R. Charrois Breakdown of academic impact, for papers by Michael Teifel Breakdown of academic impact, for papers by Sara Zalba Breakdown of academic impact, for papers by Dawn Waterhouse Breakdown of academic impact, for papers by Daniela Fraier
Rankless by CCL
2026